Please use this identifier to cite or link to this item:
http://hdl.handle.net/1893/25564
Appears in Collections: | Aquaculture Journal Articles |
Peer Review Status: | Refereed |
Title: | Microbial and genetically engineered oils as replacements for fish oil in aquaculture feeds |
Author(s): | Sprague, Matthew Betancor, Monica B Tocher, Douglas R |
Contact Email: | matthew.sprague@stir.ac.uk |
Keywords: | Alternative n-3 LC-PUFA sources Aquaculture EPA and DHA Farmed Fish Human health Oils from transgenic plants Polyunsaturated fatty acids |
Issue Date: | Nov-2017 |
Date Deposited: | 30-Jun-2017 |
Citation: | Sprague M, Betancor MB & Tocher DR (2017) Microbial and genetically engineered oils as replacements for fish oil in aquaculture feeds. Biotechnology Letters, 39 (11), pp. 1599-1609. https://doi.org/10.1007/s10529-017-2402-6 |
Abstract: | As the global population grows more of our fish and seafood are being farmed. Fish are the main dietary source of the omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, but these cannot be produced in sufficient quantities as are now required for human health. Farmed fish have traditionally been fed a diet consisting of fishmeal and fish oil, rich in n-3 LC-PUFA. However, the increase in global aquaculture production has resulted in these finite and limited marine ingredients being replaced with sustainable alternatives of terrestrial origin that are devoid of n-3 LC-PUFA. Consequently, the nutritional value of the final product has been partially compromised with EPA and DHA levels both falling. Recent calls from the salmon industry for new sources of n-3 LC-PUFA have received significant commercial interest. Thus, this review explores the technologies being applied to producede novon-3 LC-PUFA sources, namely microalgae and genetically engineered oilseed crops, and how they may be used in aquafeeds to ensure that farmed fish remain a healthy component of the human diet. |
DOI Link: | 10.1007/s10529-017-2402-6 |
Rights: | © The Author(s) 2017 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
Licence URL(s): | http://creativecommons.org/licenses/by/4.0/ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Sprague_etal_BiotechLett_2017.pdf | Fulltext - Published Version | 438.07 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
A file in this item is licensed under a Creative Commons License
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.